Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Higher comorbidity, poor functional status and higher health care utilization in veterans with prevalent total knee arthroplasty or total hip arthroplasty
Clinical Rheumatology, 06/18/09
Singh JA et al. - Study reports poorer function and higher comorbidity and utilization in veterans with total knee arthroplasty/total hip arthroplasty (TKA/THA), suggesting that this group is appropriate for interventions targeted at improving function and decreasing utilization.
Methods- Comparison of comorbidity, functional ability, and health care utilization in veterans with TKA or THA vs matched control populations
- A cohort of veterans reported limitations in 6 activities of daily living, demographics, and physician-diagnosed comorbidity
- Patients were classified as:
- Primary total knee arthroplasty (TKA)
- Primary total hip arthroplasty (THA)
- Combination group (≥1 procedure); and
- Control veteran population (no THA/TKA)
- Multivariable regression analyses compared the risk or counts of ADL limitation and in-/out-patient visits
- TKA, THA or combination groups had higher prevalence of the following, compared to veteran controls:
- arthritis, diabetes, or heart disease
- severe (≥3) ADL limitation (33%, 42%, 42% vs 24%) and
- annual hospitalization rate (24%, 19%, 26% vs 16%)
- Annual outpatient surgery visits were more and risk of any mental health outpatient visit was lower
- All ADLs, except eating, were more limited in arthroplasty groups
- Severe ADL limitation was more prevalent in veterans with arthroplasty than in two age-matched US cohorts:
- 13.4 times in ≥65 years and
- 1.2-, 1.6-, and 4-fold in ≥85, 75-84, and 65-74 years respectively
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
The use of complementary and alternative medicine in outpatients with inflammatory rheumatic diseases in Sweden
Scandinavian Journal of Rheumatology , 11/17/09
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


